<qa>  What is the name of the PATIENTs with RELAPSED OR REFRACDECITABINE AND FR901228 IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY LEUKEMIA, MYELODYSPLASTIC SYNDROMES, OR MYELOPROLIFERATIVE DISORDERS: 